We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+23.39%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$393M
AUM Growth
+$194M
Cap. Flow
+$137M
Cap. Flow %
34.84%
Top 10 Hldgs %
99.99%
Holding
12
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$143M

Top Sells

Rank Stock Value
1
CO
Global Cord Blood Corporation
CO
+$3.61M
2
SLTM
SOLTA MED INC (DE)
SLTM
+$3.01M

Sector Composition

Rank Sector Weight
1 Healthcare 86.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$145M 36.82%
+4,592,047
New +$143M
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$85.1M 21.65%
5,815,940
– –
ABMD
3
DELISTED
Abiomed Inc
ABMD
$82M 20.88%
3,150,000
– –
ELGX
4
DELISTED
Endologix Inc
ELGX
$51.5M 13.12%
116,543
– –
ACUR
5
DELISTED
Acura Pharmaceuticals
ACUR
$14.3M 3.64%
2,058,977
– –
TCRT icon
6
Alaunos Therapeutics
TCRT
$4.79M
$11.8M 3%
18,433
– –
MNOV icon
7
MediciNova
MNOV
$65M
$2.4M 0.61%
1,170,370
– –
CRIS icon
8
Curis
CRIS
$4.68M
$659K 0.17%
117
– –
CO
9
DELISTED
Global Cord Blood Corporation
CO
$347K 0.09%
86,763
-887,437
-91% -$3.61M
ECTE
10
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$37K 0.01%
12,319
– –
PTN
11
Palatin Technologies
PTN
$13.2M
$29K 0.01%
19
– –
SLTM
12
DELISTED
SOLTA MED INC (DE)
SLTM
– –
-1,020,219
Closed -$3.01M

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
LIA
LifePlan Investment Advisors Raleigh, North Carolina $254M AUM 17.26% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return

Essex Woodlands Management's Q1 2014 Portfolio in Review

As of Q1 2014, Essex Woodlands Management held 12 positions worth $393M, up 97% from $199M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management deployed $137M of net new capital in Q1 2014, opening 1 new position. Its largest new stake was Revance Therapeutics, Inc.: 4,592,047 shares worth $145M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 79% a quarter earlier.

On the sell side, the largest reduction was Global Cord Blood Corporation, an estimated $3.61M trimmed.

  • Essex Woodlands Management's largest Q1 2014 buy was Revance Therapeutics, Inc.: 4,592,047 shares worth $145M.
  • Essex Woodlands Management's biggest Q1 2014 reduction was Global Cord Blood Corporation, cutting an estimated $3.61M.
  • Essex Woodlands Management fully exited SOLTA MED INC (DE) in Q1 2014, selling an estimated $3.01M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $393M portfolio in Q1 2014.
  • Essex Woodlands Management opened 1 new position and closed 1 in Q1 2014.
  • Essex Woodlands Management's portfolio value rose 97% quarter-over-quarter to $393M.

Based on Essex Woodlands Management's 13F filing for Q1 2014, filed 15 May 2014.